MDA Stats & Data

1950–1953

During the early Cold War period, the United States Army conducted experiments with MDA under the code designation EA-1298 as part of broader efforts to develop chemical agents that could function as truth serums or incapacitating weapons. These military and intelligence programs administered relatively unexplored psychoactive compounds to both knowing and unknowing subjects with minimal ethical oversight. One such experiment proved fatal. In January 1953, a psychiatric patient named Harold Blauer died at the New York State Psychiatric Institute after being intravenously injected with 450 milligrams of MDA without his knowledge or consent. The Army had contracted with physicians at the institute to test new chemicals from Edgewood Arsenal, and Blauer's death occurred during what was reportedly his fifth injection as part of these experiments, which have since been associated with the larger Project MKUltra program.

Several researchers investigated MDA's potential applications in psychotherapy during the 1960s and 1970s. Chilean psychiatrist Claudio Naranjo extensively documented the compound's therapeutic value, publishing his findings in the book "The Healing Journey." Psychologist Richard Yensen also explored the drug's utility in clinical settings. These researchers found that MDA facilitated emotional openness and introspection in patients, foreshadowing the later interest in MDMA for similar therapeutic purposes.

1963–1992

MDA began appearing in recreational contexts around 1963 to 1964, making it the first entactogen to achieve widespread non-medical use and predating its more famous derivative MDMA by more than a decade. The compound earned nicknames including the "hug drug" and was sometimes said to stand for "Mellow Drug of America," reflecting its reputation for enhancing empathy and emotional warmth. During this period, MDA was inexpensive and readily obtainable as a research chemical from scientific supply houses, alongside other compounds like mescaline and LSD that were sold under their chemical names. This accessibility contributed to its popularity as the psychedelic movement expanded in the late 1960s. By early 1968, clandestine production had grown significantly enough that the Bureau of Drug Abuse Control reported seizing over 1.4 kilograms of MDA along with 11 kilograms of precursor chemicals from an illegal laboratory in New York. MDA experienced a notable resurgence in 1992 when a large batch of pills marketed as "Snowballs" circulated throughout the United Kingdom and Europe. These tablets unexpectedly contained MDA rather than MDMA, and were dosed at approximately 200 milligrams per pill—well into the strong to heavy dose range. This miscalculation resulted in widespread reports of intense and unexpected hallucinogenic experiences among users who had anticipated MDMA's effects, demonstrating MDA's more pronounced psychedelic character at higher doses.